Literature DB >> 9022000

The cytoplasmic domain of rat NKR-P1 receptor interacts with the N-terminal domain of p56(lck) via cysteine residues.

K S Campbell1, R Giorda.   

Abstract

NKR-P1 is a type II transmembrane protein which acts as an activation receptor on natural killer (NK) cells. The cytoplasmic domains of the CD4, CD8 and 4-1BB receptors contain the sequence Cys-X-Cys-Pro which is directly involved in coupling to another pair of cysteines in the N-terminal domain of the src family tyrosine kinase p56(lck). The cytoplasmic domain of NKR-P1 in rodents also contains the Cys-X-Cys-Pro sequence, but the capacity of the receptor to bind p56(lck) is presently unknown. We tested for direct coupling between these proteins using both protein biochemistry and the yeast two-hybrid technique. Immunoprecipitation studies showed that p56(lck) can be co-immunoprecipitated with NKR-P1 from a rat NK tumor cell line. In addition, the cytoplasmic domain of NKR-P1 interacted with the N-terminal domain of p56(lck) in yeast as assessed by reporter gene activation. Integrity of the cysteine pairs in both proteins was critical in mediating the interaction. The experiments suggest that the association of p56(lck) with NKR-P1 is somewhat weaker than the p56(lck) association with CD8alpha, but of much lower avidity than between CD4 and p56(lck). This could reflect a higher activation threshold for the NKR-P1 and CD8 receptors, which are involved in cytolytic responses, compared to CD4 which is involved in T cell helper function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9022000     DOI: 10.1002/eji.1830270111

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling.

Authors:  S M Shahjahan Miah; Amanda K Purdy; Nicholas B Rodin; Alexander W MacFarlane; Jennifer Oshinsky; Diana A Alvarez-Arias; Kerry S Campbell
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

Review 2.  NKR-P1 biology: from prototype to missing self.

Authors:  Aruz Mesci; Belma Ljutic; Andrew P Makrigiannis; James R Carlyle
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  CD161B:ClrB interactions mediate activation of enhanced lysis of tumor target cells following NK cell:DC co-culture.

Authors:  Tianbing Yang; Melanie S Flint; Katie M Webb; William H Chambers
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.

Authors:  M Exley; S Porcelli; M Furman; J Garcia; S Balk
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

5.  Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1+ T cells.

Authors:  N Arase; H Arase; S Y Park; H Ohno; C Ra; T Saito
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

Review 6.  Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems.

Authors:  Christina L Kirkham; James R Carlyle
Journal:  Front Immunol       Date:  2014-06-02       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.